Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Status:
Completed
Trial end date:
2019-02-14
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if minocycline can reduce numbness,
pain, and/or loss of motor function in patients with colorectal cancer. In this study,
minocycline will be compared to a placebo.
The study doctor can explain how the study drug is designed to work.
A placebo is not a drug. It looks like the study drug, but it is not designed to treat any
disease or illness. It is designed to be compared with a study drug to learn if the study
drug has any real effect.